Ascentage Pharma Strengthens Hematologic Cancer Pipeline with Global Clinical Advancement of APG-3288

Ascentage Pharma Group International , a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commerc...

February 09, 2026 | Monday | News
Promega Secures NMPA Approval for OncoMate® MSI Detection Kit as Companion Diagnostic for KEYTRUDA® in China

The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro...

February 05, 2026 | Thursday | News
AstraZeneca Deepens Weight Management Push With $1.2B AI-Driven Obesity Deal With CSPC

Agreement includes eight programmes, including a clinical-ready asset, plus access to advanced AI-driven peptide drug discovery platform and innovati...

February 03, 2026 | Tuesday | News
Baoting Launches World’s First County-Level “Living Laboratory” to Advance 1.5°C Proactive Health Standards

Baoting Establishes World's First County-Level "Living Laboratory," Developing 1.5°C Proactive Health Standards  Breaking with decades of capit...

February 03, 2026 | Tuesday | News
Tenacia and Golden Age Health Partner to Commercialize First-Ever Approved Treatment for CDD in China

First-ever approved treatment for CDD in China now set for commercial launch through dedicated rare disease platform Tenacia Biopharmaceutical...

February 02, 2026 | Monday | News
China’s NMPA Approves Almirall’s Seysara® for Moderate-to-Severe Acne

China’s National Medical Products Administration (NMPA) has approved Seysara®(sarecycline hydrochloride) for the treatment of inflammatory ...

January 30, 2026 | Friday | News
Argo Biopharma and Novartis Dose First Patient in Phase 2b Trial of siRNA Therapy BW-20829

Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage biotechnology company committed to developing next-generation siRNA therapies, announ...

January 27, 2026 | Tuesday | News
HanchorBio and WuXi Biologics Enter Strategic Collaboration to Advance Next-Generation Fusion Proteins

HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseas...

January 27, 2026 | Tuesday | News
Ant Group Upgrades AQ Health Assistant With DeepSearch to Support Evidence-Based Clinical Decision-Making

Ant Group  announced a major upgrade to the PC platform of its AI-native health assistant, AQ, introducing DeepSearch for clinicians, a new capabili...

January 22, 2026 | Thursday | News
China Approves Sanofi’s Myqorzo and Redemplo for Cardiovascular and Rare Metabolic Diseases

Approval of Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndrome Underscores Sanofi’s long-ter...

January 16, 2026 | Friday | News
ElpasBio Partners With Fosun Kairos to Commercialize AlloJoin® Stem Cell Therapy for Knee Osteoarthritis in Greater China

ElpasBio Holdings ("ElpasBio"), a leading clinical-stage biotechnology company focused on regenerative medicine, announced that it has entered into a col...

January 15, 2026 | Thursday | News
Nxera Pharma Secures APAC Rights to Vamorolone for Duchenne Muscular Dystrophy

Vamorolone is approved and marketed as AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD) in the US, European Union, UK and China New...

January 09, 2026 | Friday | News
HUTCHMED’s Sovleplenib Meets Primary Endpoint in Phase III ESLIM-02 Trial in wAIHA

— Delivers rapid, durable responses in wAIHA, the more common form of this potentially life-threatening disease —  HUTCHMED (China) Lim...

January 08, 2026 | Thursday | News
Eisai and Biogen Secure NMPA Acceptance for Subcutaneous LEQEMBI in China

If approved, lecanemab may become the first and only anti-amyloid treatment in China to offer an at-home injection from the initiation of treatment for...

January 07, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close